Published in:
Open Access
01-12-2015 | Poster presentation
P053. An Italian study on the actual cost/benefit of onabotulinumtoxinA (BT-A) in chronic migraine: preliminary results
Authors:
Barbara Petolicchio, Massimiliano Toscano, Martina Squitieri, Alessandro Viganò, Edoardo Vicenzini, Vittorio Di Piero
Published in:
The Journal of Headache and Pain
|
Special Issue 1/2015
Login to get access
Excerpt
In Italy, the estimated cost of chronic migraine (CM) is around six billion euros per year (Agenas, 2011) considering the health costs, the loss in working productivity and quality of life. …